Medi Caps Ltd (523144)

₹52.67▲0.08%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

Medi Caps Ltd share Performance

₹52.21
₹53.5
₹52.67
0.87%
Low
Day's Volatility:2.45%
High
1.58%
₹36.01
₹63.49
₹52.67
31.63%
Low
52 Weeks Volatility:52.17%
High
20.54%

Returns %
1 Month Return	12.18 %
3 Month Return	-3.14 %
1 Year Return	41.58 %

Market Stats
Previous Close	₹52.71
Open	₹52.71
Volume	1,704.00
Upper Circuit	-
Lower Circuit	-
Market Cap	₹65.73Cr

Company Information

Medicaps was founded in 1983 by S L Mittal and became a public limited company in 1986. It is currently the second-largest manufacturer of empty hard gelatine capsules in India, producing 3440 million capsules per annum. The company has 40 clients, including US Vitamins, SOL Pharmaceuticals, Dr Reddys Laboratories, Lupin Laboratories, Aristo Pharmaceuticals, and many others. In 1995, it raised Rs 9.19 crore to expand the manufacturing facilities by offering 6.11 lakh rights shares, and achieved zero-defect production. In 1993, the company received the Glory of India International Award, with R C Mittal receiving it personally. In 1995-96, it increased the capacity to 2500 lac, and in 1998-99, received ISO 9002 Certification. The company developed six sizes of Hard Gelatin capsules in 2002-03 and is soon commissioning its 13th Machine with 100 automisation. It is also catering to export markets in China, Thailand, Dubai, Malaysia, South Africa, and the Philippines.

Share Price: ₹52.67 per share as on 03 May, 2024 04:01 PM
Market Capitalisation: ₹65.73Cr as of today
Revenue: ₹6.92Cr as on December 2023 (Q4 23)
Net Profit: ₹0.16Cr as on December 2023 (Q4 23)
Listing date: 17 Oct, 1995
Chairperson Name: R C Mittal

Organisation	Medi Caps Ltd
Headquarters	Indore
Industry	Realty
E-voting on shares	Click here to vote

Fundamentals of Medi Caps Ltd

Insights on Medi Caps Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, MEDICAPS stock has moved up by 12.2%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 6.1 Cr → 7.16 Cr (in ₹), with an average increase of 14.8% per quarter
NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 134.2% return, outperforming this stock by 111.5%
NO EFFECT
Against Peers
In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 55.2% return, outperforming this stock by 13.6%
NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 49.84% of holdings in Mar 2024 quarter
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.13% of holdings in Mar 2024 quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 0.12 Cr → -0.16 Cr (in ₹), with an average decrease of 233.3% per quarter